Standout Papers

Evaluating a New International Risk-Prediction Tool in IgA Nephropathy 2019 2026 2021 2023 266
  1. Evaluating a New International Risk-Prediction Tool in IgA Nephropathy (2019)
    Sean J. Barbour, Rosanna Coppo et al. JAMA Internal Medicine

Immediate Impact

2 by Nobel laureates 2 from Science/Nature 57 standout
Sub-graph 1 of 20

Citing Papers

Empagliflozin in Patients with Chronic Kidney Disease
2022 Standout
Chronic kidney disease
2021 Standout
1 intermediate paper

Works of Daniel Cattran being referenced

Rituximab-Induced Depletion of Anti-PLA2R Autoantibodies Predicts Response in Membranous Nephropathy
2011
Cyclosporine in patients with steroid-resistant membranous nephropathy: A randomized trial
2001
and 1 more

Author Peers

Author Last Decade Papers Cites
Daniel Cattran 4416 1422 591 1469 80 5.5k
Daniel C. Cattran 3077 1020 438 800 82 5.0k
Laurence H. Beck 5200 2303 251 2000 112 7.0k
Heather N. Reich 3595 811 155 987 135 5.6k
Stephen M. Korbet 4312 1494 220 767 98 5.9k
James V. Donadío 2413 730 223 676 74 3.9k
Tullio Bertani 3273 890 421 440 94 6.2k
Rosanna Coppo 4598 1184 139 1171 209 6.1k
Andrew S. Bomback 2950 1046 265 369 157 4.9k
Richard Lafayette 2019 724 226 402 144 4.2k
J. Ashley Jefferson 2629 1085 105 831 50 5.1k

All Works

Loading papers...

Rankless by CCL
2026